X
Oct 08, 2021 06:08 PM (GMT+8) · EqualOcean
Cailian, October 8 (Xinhua) -- Huahai pharmaceutical announced that recently, Linhai xunqiao production base of the company received an on-site inspection report issued by FDA. The inspection report made it clear that the inspection passed with zero defect (NAI). According to the inspection report, Linhai xunqiao production base of Zhejiang Huahai Pharmaceutical Co., Ltd. meets the requirements of American drug cGMP.